Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INGENTA PLC Director's Dealing 2019

Feb 6, 2019

7708_dirs_2019-02-06_387ce485-c784-4c19-80b5-4bde5bc3b6af.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1762P

Ingenta PLC

06 February 2019

6th February 2019

Ingenta plc

Directors' Dealings

Ingenta plc (LSE:ING, "Company" or "Ingenta") received notification on 5th February 2019 from Kestrel Partners LLP ("Kestrel") that on 5th February 2019 it acquired, on behalf of its discretionary clients, 25,000 ordinary shares of 10p each ("Shares") in the Company at a price of £0.73 per share. The notification also included the matters set out below.

Kestrel is the investment manager to Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel Opportunities"), and various other clients. This disclosure relates to indirect Shares and voting rights in the Company that are managed by Kestrel on a discretionary basis.

Mr. Royde is a partner of, and holds a beneficial interest in Kestrel. Mr. Royde is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Ingenta.

Prior to this purchase of Shares, Kestrel on a combined basis indirectly held Shares and voting rights over 4,576,754 Shares in the Company.

Kestrel Opportunities holds (and consequently Mr. Royde is deemed to have a beneficial interest in) 3,425,983 Shares in the Company. The 25,000 shares were purchased on behalf of Kestrel's other discretionary clients, in which Mr Royde has no beneficial interest, who, following this transaction, hold a further 1,175,771. Shares in the Company.

Following this transaction and on a combined basis, Kestrel indirectly holds voting rights over 4,601,754 Shares in the Company, which represents approximately 27.20% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

Holding type Nominee No. of shares % of issued share capital
Indirect Bank of New York Nominees Ltd 3,425,983 20.25%
Indirect JIM Nominees Limited 281,531 1.66%
Indirect Bank of New York Nominees Ltd 894,240 5.29%

For further information contact:

Ingenta Plc

Scott Winner

Jon Sheffield
+44 (0) 1865 397 800
Cenkos Securities plc

Nicholas Wells

Harry Hargreaves
+44 (0) 20 7397 8900

ANNEX

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Kestrel Partners LLP

2

Reason for the notification

a)

Position/status

Person closely associated with Max Royde, Non-Executive Director

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ingenta plc

b)

LEI

213800QU4IVLTQZL3T37

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

10p Ordinary Shares

ISIN: GB00B3BDTG73

b)

Nature of the transaction

Purchase

c)

Price(s) and volume(s)

Price(s) Volume(s)
GBP 0.73 25,000 Shares

d)

Aggregated information

- Aggregated volume

- Price

25,000

£18,250

e)

Date of the transaction

2019-02-05

f)

Place of the transaction

AIMX

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHMMGGZRKVGLZM